NASDAQ · OABI
OmniAb, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for OABI has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.12 | $-0.11 | $-0.12 | 2 |
| Dec 2026 | $-0.12 | $-0.11 | $-0.13 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
MarketBeat · Zacks · RTTNews · NASDAQ.com- MarketBeat · Oct 25, 12:02 AM EDTOmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at ConferenceOmniAb (NASDAQ:OABI) Chief Financial Officer Kurt Gustafson outlined the company’s antibody-discovery platform, partner pipeline and revenue model during a company presentation, emphasizing a strategy built around licensing technology to pharmaceutical and biotechnology companies
- MarketBeat · Oct 7, 1:02 PM EDTOmniAb Investor Day Spotlights Royalty Pipeline, OmniTides Launch and xPloration GrowthOmniAb (NASDAQ:OABI) used its investor and analyst day to outline its strategy for expanding royalty-bearing partnerships, commercializing its xPloration screening platform and entering the peptide-discovery market through its newly introduced OmniTides platform. Management said
- Zacks · Oct 6, 11:00 AM EDTAll You Need to Know About OmniAb, Inc. (OABI) Rating Upgrade to BuyOmniAb, Inc. (OABI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- RTTNews · Sep 3, 4:08 AM EDTBiotech Stocks At 52-Week Highs – OABI +13%, FRNM, EXEL, FTH, LFST(RTTNews) – The following biotech stocks reached a 52-week high on September 2, 2026, driven by achieving new regulatory milestones or positive financial results.
- RTTNews · Aug 18, 7:03 AM EDTBiotech Stocks At 52-Week Highs – OABI, IOVA, PBLS, RVMD, BLFS(RTTNews) – The following biotech stocks reached a 52-week high on August 17, 2026, driven by key catalysts including prospective clinical trial results and announced acquisitions.
- NASDAQ.com · Aug 17, 8:29 AM EDTPre-Market Most Active for Aug 17, 2026 : SNAP, NOK, OABI, SPCX, MUU, TQQQ, SQQQ, AAPL, PATH, BP, NWG, ORCLThe NASDAQ 100 Pre-Market Indicator is up 55.12 to 30,101.26. The total Pre-Market volume is currently 152,246,924 shares traded.The following are the most active stocks for the pre-market session: Snap Inc. (SNAP) is -0.2497 at $5.16, with 22,477,282 shares traded. SNAP's curre
- The Motley Fool · Aug 14, 6:58 AM EDTOmniAb (OABI) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 7, 2:04 AM EDTOmniAb Q2 Earnings Call HighlightsOmniAb (NASDAQ:OABI) reported higher second-quarter revenue and a narrower net loss as milestone payments from partner programs increased, while the company raised its full-year 2026 revenue and year-end cash outlook. Revenue for the second quarter totaled $13.4 million, compare
- Zacks · Aug 6, 7:10 PM EDTOmniAb, Inc. (OABI) Reports Q2 Loss, Beats Revenue EstimatesOmniAb, Inc. (OABI) delivered earnings and revenue surprises of +54.55% and +149.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · May 8, 10:10 AM EDTOmniAb (OABI) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · May 8, 7:07 AM EDTOmniAb Q1 Earnings Call HighlightsOmniAb (NASDAQ:OABI) reported first-quarter 2026 results that management characterized as a “very strong start to the year,” driven primarily by clinical progress across its partner portfolio and associated milestone revenue. Partner program progress drives revenue outperformanc
- Zacks · May 7, 10:25 PM EDTOmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue EstimatesOmniAb, Inc. (OABI) delivered earnings and revenue surprises of +40.00% and +164.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for OmniAb, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.